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ABSTRACT
We developed a functional selection system based
on randomized genetic elements (GE) to identify
potential regulators of hepatitis C virus (HCV) RNA
translation, a process initiated by an internal riboso-
mal entry site (IRES). A retroviral HCV GE library was
introduced into HepG2 cells, stably expressing the
Herpes simplex virus thymidine kinase (HSV-TK)
under the control of the HCV IRES. Cells that
expressed transduced GEs inhibiting HSV-TK were
selected via their resistance to ganciclovir. Six
major GEs were rescued by PCR on the selected
cell DNA and identified as HCV elements. We vali-
dated our strategy by further studying the activity of
one of them, GE4, encoding the 5’ end of the viral
NS5A gene. GE4 inhibited HCV IRES-, but not cap-
dependent, reporter translation in human hepatic
cell lines and inhibited HCV infection at a post-
entry step, decreasing by 85% the number of viral
RNA copies. This method can be applied to the iden-
tification of gene expression regulators.
INTRODUCTION
In order to identify hepatitis C virus (HCV) genetic ele-
ments, either RNA sequences or protein domains, that
may modulate the viral genome translation, we developed
a functional selection procedure adapted from the genetic
suppressor element (GSE) strategy, which acts by down-
regulating a target gene through an inhibitory antisense
RNA or a trans-dominant peptide (1).
HCV is a single-stranded RNA virus provoking
a chronic liver inﬂammation, likely to evolve toward cir-
rhosis and hepatocellular carcinoma (2). HCV lifecycle as
well as the functions of some HCV proteins are not yet
fully elucidated (3). After HCV entry into target cells, the
9.6-kb viral RNA genome is translated as a single open
reading frame into a precursor polyprotein cleaved by host
and viral proteases to give rise to structural and non-
structural viral proteins. The non-structural HCV proteins
form a membrane-associated replication complex with the
viral RNA and are suﬃcient for replication of the viral
genome. They are not contained in the virus particles, and
therefore HCV RNA replication totally depends upon eﬃ-
cient translation. The structural proteins assemble with
the neo-synthesized viral RNA copies to form progeny
virions. The HCV RNA genome is ﬂanked on either side
by untranslated regions (UTRs), crucial for viral gene
expression. The 50 UTR is folded in several stem-loop
domains acting as an internal ribosome entry site (IRES)
initiating translation by a cap-independent mechanism
(4–6). The 50 UTR also contains sequences essential for
replication (7) and regulation of viral RNA abundance
(8). Because of its peculiarity in promoting persistent
infection, HCV has been suggested to modulate its own
expression, in order to maintain the replication level below
the threshold hampering host cell viability. Some viral
proteins contribute to the balance between translation,
replication and packaging steps of the viral RNA, as
part of the virus strategy to control its lifecycle. Indeed,
HCV core, NS4A, NS4B and NS5A proteins have been
proposed to regulate HCV translation (9–14).
Our strategy uses a retroviral library of randomized
HCV genetic elements (GE) for transducing recipient
cells stably expressing the Herpes simplex virus thymidine
kinase (HSV- TK) gene under the control of the HCV
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marker: upon addition of ganciclovir (GCV), a nucleoside
analogue, to the cultured cells, HSV-TK phosphorylates
GCV, which turns into a genotoxic metabolite, leading to
subsequent cell death. Transduced cells expressing a HCV
library-derived GE able to inhibit the IRES-mediated
synthesis of HSV-TK will survive the GCV treatment. In
rescuing those elements integrated in GCV-resistant cells,
we identiﬁed six major HCV sequences. We investigated
the activity of one of them encoding the N-terminal
domain of the NS5A protein, and showed that it inhibited
HCV IRES-mediated translation and hence HCV replica-
tion in cultured cells.
MATERIALS AND METHODS
RandomHCV fragment library
pGEM-HCV containing the full-length HCV H77 cDNA
(C. Wychowski, unpublished data) was fragmented by
DNAse I in the presence of Mn
2+, according to (1). The
fragment termini were rendered blunt-end by Klenow-
(Invitrogen, Cergy-Pontoise, France) and Pfu-
(Stratagene, Amsterdam-Zuidoost, Netherlands) DNA
polymerases and ligated with a 50-fold excess of 50–phos-
phorylated synthetic adaptors [50AATCATCGATGGA
TGGATGG30 (sense) 50CCATCCATCCATCGATGA
TTAAA30 (antisense)], in the presence of T4 DNA ligase
(Invitrogen). These adaptors contained the Cla I site and
ATG-initiating codons in the three diﬀerent reading
frames. After fractionation by agarose gel electrophoresis,
the mixture of 100–300bp DNA fragments was recovered
from the gel, digested by Cla I (Roche, Meylan, France)
and cloned into the Cla I site of the pLNCX retroviral
vector (Clontech, Saint-Germain-en-Laye, France). Fifty
thousand independent recombinant clones were pooled
to generate the HCV-pLNCX library.
Generationof thereporter cell line
The pIF-TK-30NC expression vector contains the
sequences of the ﬁreﬂy luciferase (Fluc) gene, HCV
50UTR (HCV H77, nt 1–371), HSV-TK gene and the
HCV 30UTR (HCV H77, nt 9376–9647), in the
pcDNA3.1 Zeo vector (Invitrogen). Therefore, the
HSV-TK coding sequence was obtained by PCR, using
the pGT60-mcs plasmid (Invivogen, Toulouse, France)
as template and the primers 50AACCTCAAAGAAA
ACTGCAGATCTTGGCCTCGTACC30 (forward) and
50CTACACAGTGAGCGGCCGCGTCGACTCAATCT
AGTC30 (reverse). The PCR product was cloned between
PstI and NotI sites into the pIRF expression vector [pro-
vided by A. Cahour, (11)], from which the Renilla lucifer-
ase (Rluc) gene has been excised, so that HSV-TK was in
frame with the HCV IRES AUG341. Finally, the HCV
30UTR obtained by PCR was inserted between NotI and
XhoI sites.
HepG2 cells (grown in DMEM supplemented with
10% fetal calf serum, 2mM L-glutamine and 1% non-
essential amino acids, at 5% CO2) were transfected
with pIF-TK-30NC, using FuGENE (Roche), and selected
with 0.5mg/ml zeocin (Invitrogen) for 2–3 weeks.
They were then cloned in the presence of 0.7mg/ml
zeocin and screened for Fluc activity, using the
Luciferase Assay System (Promega, Charbonnie ´ res-
les-Bains, France), and GCV sensitivity. B1 was one of
those clones. The Hep-TK cell line was obtained by
pGT60-mcs tranfection in the same conditions as above,
except that they were selected with hygromycin at
0.2mg/ml (Invivogen). The transgene expression in both
reporter cell lines was routinely checked by northern blots
of HSV-TK mRNA, Fluc activity and GCV sensitivity.
Retroviral library production and transduction in target cells
HEK 293T cells (3 10
6 per 6cm diameter tissue culture
dish) were transfected with 3.5mg of HCV-pLNCX library
(or insert-free pLNCX for the control), 5mg of pVPack-
GagPol (Stratagene) and 3mg of pVPack-vesicular stoma-
titis virus G protein (Stratagene), using the calcium phos-
phate procedure. Two days after transfection, the
retroviral supernatant was harvested and ﬁltered through
a 0.45mm ﬁlter. B1 cells (8 10
4 per 10cm diameter cul-
ture dish) were infected with 3ml of either HCV library or
insert-free retroviral supernatant, mixed with 10mg/ml
DEAE-Dextran (Sigma, Saint-Quentin Fallavier,
France). The eﬃciency of retroviral vector transduction
on B1 cells was monitored using a pLNCX-DsRed
vector, producing the red ﬂuorescent protein Ds-Red
(Clontech, Saint-Germain-en-Laye, France), and was
found to be higher than 50% in these conditions. The
transduced cells were grown in a non-selective culture
medium for a week, and then treated by 140mM GCV
([9-(1,3-dihydroxy-2-propoxy)methyl]guanine; Invivogen)
for one month, changing the medium every 2–3 days.
The surviving cells were expanded and 8 10
4 cells per
10cm diameter culture dish were exposed again to
140mM GCV for a month.
RESCUE OF THE HCV FRAGMENTS FROM THE
SELECTED CELLS AND SUB-CLONING
Isolated B1 colonies surviving GCV treatment were picked
and grown individually. HCV fragments were rescued by
PCR from the DNA of the selected cells as in (1), using
the primers 50GCCCCAAGCTTGTTAACAACGATG
GATG30 (forward) and 50ATGGCGTTACTTAAGCT
AGCTCGCCAAACCTAC30 (reverse). The forward
primer was designed to eliminate the ClaI site and to pro-
vide a HindIII site. The PCR products were cloned into
the TOPO-TA vector (Invitrogen) and sequenced using
the reverse primer mentioned above. The inserted HCV
fragments were identiﬁed as sequences inserted between
the adapter sequences and veriﬁed to belong to HCV
H77. The PCR products were digested by HindIII and
ClaI (Roche) and ligated into the corresponding sites of
the pLHCX retroviral vector (Clontech), carrying the
hygromycine phosphotransferase gene. Retroviral trans-
duction of each selected fragment was done as above in
HepG2 or Huh7 cells, except that the transduced
cells were further enriched by hygromycin selection
(0.3mg/ml; Invivogen) for 10 days. The expression of
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PCR, using the same primers as above.
Cell viability assay
Cells were grown in a 96 well microplate, starting at 2000
cells per well. Cell viability was assessed using the
CellTiter96 AQueous One Solution Reagent (Promega,
Charbonnie ´ res-les-Bains, France) and a spectrophoto-
metric microplate reader (Bio-Tek, Winooski, VT, USA).
In vitro transcriptionof RNA
The pIRF-derived pIRF-30NC vector, containing the HCV
H77 30UTR inserted between the NotI and XhoI sites,
was linearized by XhoI and transcribed using the
Amplicap
TM T7 High Yield transcription kit (TEBU, Le
Perray en Yvelines, France). The plasmids pFK-I389 luc/
NS3-3/5.1, containing the subgenomic replicon HCV 1b
sequence and the Fluc gene, and pFK-I389luc/NS3-30/
GND carrying the unactivating GND mutations in the
NS5B gene [provided by R. Bartenschlager (15)] were lin-
earized with ScaI and transcribed using the MEGAscript
transcription kit (Ambion, Courtaboeuf, France). Capped
RNA of the GEs were obtained by transcription of PCR
products ampliﬁed from the corresponding pLHCX vector
with the primers 50 TAATACGACTCACTATA
GGGATCAACGATGGATGGATGG30(T7-forward, ini-
tiating codons in bold) and 50CCATCCATCCATCGA
TGATTAAA30 (reverse). The initiating AUG were
mutated stepwise by successive PCRs, using T7-forward-
mut primers, in which the ﬁrst ATG (mut1), the 1st and
2nd (mut2) or the 3 ATG (mut3) were mutated in CTG.
Finally, the ﬁrst AUG was rescued using PCR product
(mut3) as a template and a T7-forward-mut primer in
which the ﬁrst initiating codon was ATG and the 2nd
and 3rd CTG (ATG1). At each step, the PCR products
were puriﬁed (Qiagen, Courtaboeuf, France) and tran-
scribed using the Amplicap
TM T7 transcription kit
(TEBU). The synthesized RNAs were treated by RQ1
DNAse, puriﬁed on RNeasy columns (Qiagen) or by
acidic phenol:chloroform 5:1 extraction, and quantiﬁed
by UV-absorbance at 260nm. Their quality was veriﬁed
by agarose gel electrophoresis and ethidium bromide
staining.
RNA transient transfection
Huh7 cells (5 x 10
4 per well) were seeded into a 24-well
plate and grown for 24h in DMEM supplemented with
10% fetal calf serum, 2mM L-glutamine and 1% non-
essential amino acids. pIRF-30NC or replicon RNA (150
femtomoles) was mixed to 200ml of serum-free DMEM
containing 2ml DMRIE-C transfection reagent
(Invitrogen) and immediately added to the cell layers,
that were incubated at 378C. At 18h post-transfection,
the cells were lysed in 100ml ice-cold lysis buﬀer, and the
luciferase activities were measured using the Dual
Luciferase Assay (Promega) and normalized for total pro-
tein content, which was measured by the Bradford assay
(Bio-Rad, Marnes-la-Coquette, France).
HCV production and infection
The plasmid pJFH1 containing the full-length cDNA of
JFH1 isolate [provided by T. Wakita (16)] has been used
to generate genomic HCV RNA, which was delivered to
Huh7 cells by electroporation, as described previously
(17). Viral stocks of about 10
7 JFH1 RNA copies/ml
were obtained by ampliﬁcation on Huh-7 cells. 5 10
4
Huh7 cells per well were plated into 24-well plates and
infected 24h later with JFH1 stocks. For HCV immuno-
detection, the cells were ﬁxed with 3% paraformaldehyde,
permeabilized with 0.1% Triton X-100, and labeled with
anti-E2, as described (17).
Quantitative RT–PCR
Total RNA was extracted using Trizol reagent
(Invitrogen). qRT-PCR ampliﬁcations were conducted
on 50ng of total RNA using the MyiQ TM real-time
system and the iScriptTM One-Step RT-PCR with
SYBR Green kit (both from, Bio-Rad). HSV-TK
[50GTACCCGAGCCGATGACTTACT30 (forward), 50C
CCGGCCGATATCTCA30 (reverse)] and GAPDH
[50GTACCCGAGCCGATGACTTACT30 (forward),
50CCCGGCCGATATCTCA30 (reverse)] primers were
used at 0.3mM. Reactions were performed in 25ml under
the following conditions: step 1, 10min at 508C; step 2,
5min at 958C; step 3, 40 cycles with one cycle consisting of
10s at 958C, 30s at 628C and 30s at 728C. HSV-TK and
GAPDH copy numbers were determined by comparison
to serially diluted transcripts included in the RT–PCR
analysis. JFH1 RNA was quantiﬁed under the same con-
ditions as above, except that primers in the NS3 region
were used [50GGTCATCACGGTCCTGACTCC30 (for-
ward) 50TGTCTCAACGGGGATGAAAT30 (reverse)]
and a 30s at 848C step was added at each step 3 cycle.
Invitro translation assay
RNA (500ng) encoding either GE1 or GE4 were trans-
lated for increasing periods of time at 308C in a ﬁnal
volume of 20ml containing 1ml amino acid mixture and
14ml nuclease-treated rabbit reticulocyte lysate (RRL)
(Promega), thus providing RRL1. The reaction were
started by amino acid addition and stopped on ice. In a
second step referred to as RRL2, 100ng pIRF-30NC RNA
were translated for 15min at 308C in the presence of 1ml
amino acid mixture, 13ml RRL and 2ml RRL1. The reac-
tion was started by amino acid addition and stopped by
RNAse A (5mg/ml ﬁnal). Fluc and Rluc activities in RRL2
were measured using the Dual Luciferase Assay
(Promega).
Peptide synthesis
The peptides used in this study were purchased at
NeoMPS (Strasbourg, France), and solubilized in sterile
water at 10mM, except W20L which was soluble in 10%
DMSO at 3mM.
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We generated an HCV-derived GE library by random
HCV cDNA fragmentation. A 100–300bp size limit of
the fragments was chosen ﬁrst because 30–100 amino
acids could be in the range of the size of HCV proteins
domains (3) and second, because nucleic acids of that
length hybridize strongly enough to be eﬃcient antisense
GEs. Longer fragments might cover the whole IRES or
some VHC proteins of small size, likely to provide eﬃcient
but not novel GEs. Fragments were inserted into a retro-
viral expression vector under the control of a robust pro-
moter, allowing not only their clonal distribution but also
their stable expression in mammalian cells, either as sense
or antisense RNAs. In addition, these fragments could be
translated into peptides from one of the start codons in all
three open reading frames. Beside the random library,
another premise for the GE selection is a stable reporter
system in recipient cells. To this end, the bicistronic vector
pLuc-IRES-HSVTK-30UTR carrying the cap-dependent
Fluc and the HCV IRES-dependent HSV-TK was trans-
fected into human hepatic HepG2 cells and several stable
transfectants were obtained, among which the B1
clone was chosen for its high luciferase activity and sensi-
tivity to GCV.
Selection of HCV fragments inhibiting HCV IRES activity
B1 cells were infected with pLNCX-derived retroviruses
carrying the HCV GE library and subjected to GCV selec-
tion at 140mM, corresponding to the IC90 for non-infected
parent B1 cells. A control selection was performed in par-
allel on B1 cells infected with insert-free pLNCX-derived
retroviruses. After two passages in the selective medium,
many HCV library-transduced B1 cells survived to GCV
selection, in contrast to control cells, all of which died
(Figure 1a). Fifty surviving B1 colonies were picked and
analysed individually for their GCV-resistant phenotype
and Fluc activity. Most of them were resistant to high
GCV concentrations, whereas their Fluc activity was
found to be at least 60% that of control cells: Figure 1b
shows the phenotype of ﬁve B1 clones surviving the selec-
tion, as an example. The detection of Fluc activity conco-
mitantly to the loss of sensitivity to GCV ruled out the
possibility of either the loss or the repression of the bicis-
tronic transgene to explain GCV-resistance of the selected
B1 colonies.
Characterization ofthe selected HCV elements
PCR analysis of the integrated proviral inserts revealed
that each selected B1 colony contained one to three frag-
ments of the starting HCV library, the size of which
ranged from 50 to 195bp. The PCR products were
cloned in the same orientation as in the parental B1
colony. Six major HCV GE, homologous to ﬁve diﬀerent
regions of the HCV genome, were obtained out of the 50
clones, with a frequency of 15–50%. Five of them were
sense-oriented, i.e. corresponded to the HCV
RNA+strand, and in frame of the adaptor ﬁrst AUG,
suggesting that they are likely to act by encoding peptides
derived from C, NS3, NS4B, NS5A or NS5B genes
(Table 1), rather than antisense RNAs. GE6, the unique
antisense-oriented GE, was identiﬁed in the NS5B region.
GE4, 195 nucleotides long, was actually a composite ele-
ment of fragments from the NS5A gene on the 50 side of
the sequence and from the core gene on the 30 side; 15nt in
the 34nt overlap between the 30 end of the NS5A fragment
(HCV H77nt 6359–6392) and the 50 end of the core frag-
ment (nt 635–669) were conserved in both sequences.
Surprisingly the core gene derived sequence in GE4 con-
stituted the GE1 element (Table 1). Moreover, we
observed that GE4 and GE1 on the one hand, and GE5
and GE6 on the other hand, were always selected together.
The ability of the selected GEs to individually confer
GCV resistance was evaluated by the cell viability assay
after individual retroviral transduction into B1 cells. With
a GCV IC50 over 100mM, GE3, GE4 and GE5 promoted
GCV resistance in B1 cells (Table 1). GEs 1, 2 or 6, the
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Figure 1. Selection of HCV genetic elements conferring resistance to
GCV in B1 cells. (a) Typical plates of control B1 cells transduced with
insert-free retroviral vector (left) or B1 cells transduced with the retro-
viral HCV fragment library (right), after the second round of selection.
In each selection round, transduced B1 cells were treated by 140mM
GCV for 1 month. Colonies were stained with crystal violet. (b) GCV
resistance of individual selected B1 colonies. Each B1 colony picked
from the selected HCV library-transduced cells was expanded, plated
in a 96-well plate and treated for 2 weeks with increasing GCV doses,
from 0 (white bars), 40, 60, 80, 100–120mM (black bars). The results
are expressed as the percentage of living cells (measured by the cell
viability assay; see ‘Materials and Methods’ section) grown in the
absence of GCV (mean SEM of duplicates). Control B1 cells and
ﬁve representative colonies annotated A to E are shown. GCV IC50
deduced from these results, as well as the Fluc activity relative to that
of control B1 cells, measured on 10
6 exponentially growing cells, are
indicated.
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(45mM), were considered inactive. We noticed no pertur-
bation of cell growth in any GE-transduced cell line, as
compared to either parental or control B1 cell lines (data
not shown).
GE4 effecton HCV RNA expression models
We chose GE4 for further investigation, because it individ-
ually reproduced the phenotype it was selected for,
i.e. GCV resistance of B1 cells, suggesting that it might
be a potential inhibitor of HCV IRES-dependent transla-
tion. We veriﬁed that Fluc activity was unchanged
in GE4-transfected as compared to control B1 cells
(107.1% 4.4 of control cells, n=4), as well as the
amount of HSV-TK mRNA relative to GAPDH mRNA
(2.77 1.31 for GE4 versus 1.15 0.34 for control, n=4).
These results exclude an eﬀect of GE4 on transcription of
the bicistronic reporter transgene in B1 cells. Interestingly,
GE4 did not alter GCV sensitivity of HepG2 cells expres-
sing the HSV-TK gene in a cap-dependent manner
(19 6mM for GE4, versus 17.5 8.1mM for control,
n=3), corroborating its lack of eﬀect on cap-dependent
translation on the one hand, and excluding a possible eﬀect
on TK enzymatic activity, GCV uptake, metabolism or cell
death signaling, on the other hand. All together, these
results are consistent with a GE4-induced inhibition of
HCV IRES-mediated HSV-TK translation.
In order to validate its activity on other recipient cells
and HCV IRES-dependent reporters, GE4 was introduced
into Huh7 cells by retroviral transduction, and control
cells were transduced with the empty retroviral vector.
In contrast to HepG2 cells, the human hepatic Huh7
cells are currently considered to be the most permissive
for HCV RNA expression models, including subgenomic
replicons (15) and production of infectious virions (16).
GE4 eﬀect on RNA translation was ﬁrst determined by
transient transfection of pIRF-30NC RNA, in which Fluc
and Rluc (Renilla luciferase) ORFs were translated by cap-
and HCV IRES-dependent mechanisms, respectively.
As shown in Table 2, HCV IRES-dependent Rluc, but
not cap-dependent Fluc, was markedly inhibited in
GE4–Huh7 as compared to control cells. Next, GE4
eﬀect was assessed using the HCV replicon, which carries
the Fluc mRNA under the HCV IRES control. During the
18h period post- transfection, the replicon RNA was
poorly replicated, but mainly translated, as indicated by
quite similar luciferase values obtained with replication-
competent or defective replicons (data not shown). As
shown in Table 2, normalized replicon Fluc activity was
decreased by 80% in GE4-expressing cells as compared
to control cells, whether the replicon was replication-
competent or defective, indicating that GE4 greatly
impaired HCV replicon translation.
Last, we evaluated the GE4 eﬀect on an HCV infection
model in Huh7 cells from the HCV JFH1 strain (16). Both
control and GE4-Huh7 cells were incubated with infec-
tious HCV JFH-1 supernatant and analyzed for JFH1
E2 protein and genomic RNA 40h later, during which
the virus fulﬁlled its lifecycle. JFH1-infected cells were
revealed by immunoﬂuorescent staining of HCV E2 pro-
tein. Whereas no ﬂuorescent cells were visible in non-
infected cells (Figure 2a), infected cells are grouped in
foci of 15–20 ﬂuorescent cells in control Huh7 cell layer
(Figure 2b). The number of ﬂuorescent cells in GE4-
expressing Huh7 cultures was noticeably reduced, as
shown in Figure 2c as a representative ﬁeld, suggesting
that GE4 impaired JFH-1 viral lifecycle in those cells.
This antiviral eﬀect was measured using quantitative
RT-PCR of JFH1 RNA, the replication of which depends
on its translation. The amounts of viral RNA extracted
from GE4-expressing cells were similar to that of control
cells at 2h post-infection, but were severely reduced there-
after, reaching 16.2 7.9% of that of control cells at 40h
post-infection (Figure 2d). These results indicate that GE4
inhibited the replication cycle of HCV likely by interfering
with a post-entry step.
Analysisof GE4 mechanismof action on translation
We used a two-step cell-free translation assay to determine
if GE4 acted as RNA or peptide, and, if it acted as
a peptide, from which reading frame it was translated.
Indeed the retroviral vector constructs were designed in
such a way that they could be translated in any of the
three reading frames. GE4 RNA was ﬁrst translated for
increasing periods of time in RRL, thus providing RRL1
mixture. Identical RRL1 volumes, i.e. those containing
the possible GE4 translation product, withdrawn at
increasing GE4 RNA translation times, were then added
to a second translation mixture (RRL2) containing pIRF-
30NC RNA to determine the eﬀect on cap- and HCV
Table 1. Characteristics of the selected HCV genetic elements (GE)
GE Frequency
a (%) Size (nt) Region
b HCV gene
d Orientation GCV IC50
c (mM)
1 50 77 635–712 Core Sense 33.5 8.4
2 25 64 4758–4822 NS3 Sense 74 30
3 15 61 6039–6100 NS4B Sense 104.6 26
4 25 195 6246–6392
635–712
NS5A
Core
Sense
Sense
>120
5 40 66 7623–7689 NS5B Sense >120
6 50 56 9023–9079 NS5B Anti sense 42.8 12.7
anumber of B1 colonies containing the GE relative to the total number of selected colonies (each selected B1 colony contained 1–3 GE).
bRegion of the HCV H77 strain genome corresponding to the GE.
cValues deduced from a cell viability assay realized as in Fig. 1b.
dViral gene from which the GE was derived.
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Fluc and Rluc activity in RRL2 were decreased in the
function of GE4 translation time in RRL1, i.e. of increas-
ing amounts of GE4 translation product. Unlike GE4,
GE1, concomitantly selected with GE4 but individually
inactive in B1 cells (Table 1), did not aﬀect Fluc or Rluc
much more than the control RRL1 incubated without
RNA. We used this two-step translation assay to deter-
mine the activity of GE4-mut, in which the reading frames
were successively mutated: neither GE4-mut1, GE4-mut2
or GE4-mut3 exerted an inhibition as strong as wild type
GE4 (Figure 3b). Rescuing the ﬁrst AUG in GE4-mut3
RNA restored a 50% inhibiting activity on both Fluc and
Rluc. These results show that the GE4 translation product
starting at the ﬁrst AUG, rather than GE4 RNA, was
responsible of the inhibition of pIRF-30NC RNA transla-
tion. They also revealed that the activity of GE4 in the
cell-free assay was not limited to HCV IRES-dependent
translation, but also aﬀected the cap-dependent one, con-
trary to what we observed in cells.
GE4 RRL1 was found to give rise to a 6kDa peptide
(Figure 3c), in agreement with the expected 58 amino acid
sequences starting at the ﬁrst AUG codon (Figure 3d).
The 2nd and 3rd start codons would have led to 10 and
23 amino acid peptides, respectively, which could not be
seen on the Figure 3c gel. This hypothetical 58 mer
sequence contains at the N-terminus 7 amino acids
belonging to NS4B, the N-terminal NS5A region (amino
acids 8–50), followed by a sequence (amino acids 51–58)
resulting from the translation of GE1 in a frame diﬀerent
from that of the HCV core protein, giving rise to a stop
codon. Interestingly, the GE4 peptide sequence includes
the whole N-terminal NS5A membrane anchor, which
is organized in an amphipathic a-helix (27). We then
synthesized a series of ﬁve overlapping peptides spanning
the GE4 sequence (Figure 3d), and tested the activity of
each of them in the RRL translation assay, using pIRF-
30NC reporter RNA. This screening revealed the strong,
dose-dependent inhibition induced by W20L of both FLuc
and RLuc activities, as compared to the other peptides
(Figure 3e). W20L was more eﬃcient at inhibiting RLuc
than Fluc, so that the RLuc/FLuc ratio was 0.46 0.08%
of 25mM of W20L. The combination of D19I and E20G,
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Figure 2. Antiviral eﬀect of GE4. (a–c). Immunodetection of HCV E2
protein in HCV-infected Huh7 cells. Control (b) or GE4-transfected (c)
Huh7 cells were grown on glass coverslips and incubated with 50-fold
diluted JFH1 stock for 2 days. Non-infected cells (a) were used
as negative control (X bar=25mm). (d) Post-infection kinetics of
HCV RNA copy number in GE4-transfected Huh7 cells. Control or
GE4-transfected Huh7 cells were incubated with undiluted JFH1 stock
for 2h at 378C. After extensive washes, the cells were incubated further
for 4, 18 and 38h at 378C. At the indicated post-infection time, total
RNA was extracted and JFH1 RNA copies were measured by qRT–
PCR and normalized to total RNA. The results are expressed as the
percentage of normalized JFH1 copy number of control cells
(mean SEM of two independent experiments).
Table 2. Eﬀect of GE4 on HCV IRES-dependent translation, using
transient transfection of reporter RNA into Huh7 cells
Luciferase activity
in GE4-Huh7
cells (% control)
Tranfection of pIRF-30NC RNA
Cap-dependent Fluc 97.3 8.4
IRES-dependent Rluc 54.8 0.9
Transfection of HCV replicon RNA
Replication competent replicon 25.4 4.0
Replication defective replicon 19.6 4.1
Control (transduced with empty pLHCX) or GE4-expressing Huh7
cells (transduced with GE4-pLHCX) were grown in 24-well
plates before being transfected with 150 femtomoles/well of reporter
RNA: either pIRF-30NC RNA with cap-dependent Fluc and HCV
IRES-dependent RLuc (a), or HCV Luc-replicon RNA with HCV
IRES-dependent Fluc (b). Fluc or Rluc activities were measured 18h
post-transfection and normalized for total protein content. The
results are expressed as percent of normalized luciferase in control
cells (mean  S.E.M of three independent experiments).
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Figure 3. Analysis of GE4 mechanism of action on translation. (a) Result of a typical two-step translation assay using RNA encoding GE1(squares),
GE4 (circles) or no RNA (diamonds), incubated in RRL1 for the indicated period of time: cap-dependent Fluc (open symbols, lower ﬁgure) and
HCV IRES-dependent Rluc (closed symbols, upper ﬁgure) activities in RLL2 are expressed as absolute RLU (  10
6) values per assay (mean SEM
of triplicate). (b) Eﬀect of mutations in GE4 RNA on cap-dependent Fluc (light bars) and HCV IRES-dependent Rluc (dark bars) activities. GE4
RNA, either wild-type (GE4) or mutated at the level of the ﬁrst AUG (mut1), the 1st and the 2nd AUGs (mut2), the 3AUGs (mut3) or the 2nd and
3rd AUGs (AUG1), was translated in RRL1 as in Figure 3a. The results are expressed as the percentage of RRL2 luciferase activity without RNA,
obtained with a 45-min RRL1 (mean SEM of at least four experiments). (c) SDS–PAGE of the translation product of GE4 RNA (right lane),
indicated by an arrow. GE4 RNA has been translated for 45min in RRL1 mix, in the presence of S
35-methionine, as recommended by the
manufacturer. In the left lane, no RNA has been added. (d) Amino acid sequence of GE4 and GE4-derived synthetic peptides. The NS5A
N-terminal membrane anchor domain is underlined. The amino acids L12–A32 form an amphipatic a-helix (boxed). (e) The synthetic peptides
and the W20L solvent (0.2% DMSO) were tested for their eﬀect on pIRF-30NC RNA translation in the RRL2 translation assay. The luciferase
activities are expressed as the percentage of activity in the absence of peptide (mean SEM of three independent experiments).
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of W20L. Taken together, these results indicate that the
activity of GE4 on translation may be related to a
sequence spanning the NS5A amphipathic a-helix. The
fact that GE4 and W20L aﬀected both HCV IRES- and
cap-dependent translation suggests that they may directly
interact with a factor of the translation machinery.
DISCUSSION
In order to identify regulators of HCV translation in cul-
tured cells, we developed a combinatorial approach
inspired from the genetic suppressor element strategy
(1,18–23), generating an original GE library derived
from the viral genome, as well as recipient cells expressing
a selectable reporter gene under the control of the targeted
HCV IRES. Without using high-throughput sequencing
facilities, we isolated six HCV genome derived-elements,
which were present in at least 15% of the selected cell
clones. All but one were sense-oriented and likely to act
as peptides. None of the HCV fragments rescued in our
study were antisense to the HCV RNA IRES or 30UTR
actually present in our reporter system, suggesting that
antisense GEs had no selective advantage in our experi-
mental conditions. The greater eﬃciency of phenotype
suppression by peptides rather than by antisense con-
structs has been observed in other applications of the
genetic suppressor element strategy (18,19). However,
during our selection, the active GEs clearly did not act
as negative trans-dominant peptides of the viral proteins
they are derived from, because these are absent in our
recipient system.
Three of the six selected GEs were individually active,
namely GE3, 4 and 5, but their activity appeared unre-
lated to the frequency of their presence in the B1 clones, as
shown, for example, by GE1, individually inactive despite
being the most frequent (Table 1). The reason for this
discrepancy is unclear. It could reveal that the GCV selec-
tion was not strong enough or uncompleted, still leaving
false positives, as previously mentioned (1). Alternatively,
the coincidence of couples of GEs in the same B1 clone,
like GE1 and GE4 for instance, may not be fortuitous:
whether the properties of some of the selected GEs are
functionally additive or synergistic would have to be
examined (24).
The well-studied HCV genome and protein structures
allowed association of the active, selected GEs to known
functional domains. GE3 encodes a sequence located next
to the fourth transmembrane segment of the HCV non-
structural protein NS4B (25). GE5 is a region in the
N-terminal ‘ﬁngers’ of the HCV RNA-dependent RNA
polymerase (26). GE4 encodes the N-terminal NS5A
region including the totality of the membrane anchor
domain, which is structured in an amphipathic a-helix
(27). We studied the GE4 activity on translation to vali-
date our selection. GE4 inhibited HCV IRES-dependent
translation independently of recipient cells, reporter
gene and HCV strain, without apparently aﬀecting
cap-dependent translation, since stable GE4 transfectants
could be selected either in HepG2 or Huh7 cells.
Accordingly, this sequence was able to inhibit HCV infec-
tion. A cell-free assay containing the cell components
necessary for protein synthesis allowed us to specify that
GE4 was functioning as a peptide rather than RNA, and
that its active part was related to the NS5A-derived pep-
tide likely to fold as an amphipathic a-helix. The main
function of NS5A N-terminal domain is to anchor this
non-structural protein, mandatory to HCV replication,
to intracellular membrane through an in-plane amphi-
pathic a-helix structure interacting with the cytosolic
membrane leaﬂet (28). The current hypothesis is that mul-
tiple NS5A dimers could form a two-dimensional array on
intracellular membranes, thereby creating a ‘railway’ that
would allow RNA sliding (3). Interestingly, mutations
aﬀecting the positioning of fully conserved residues
located at the cytosolic surface of the NS5A amphipathic
a-helix impaired HCV RNA replication without interfer-
ing with NS5A membrane association, suggesting that the
N-terminal helix performed some additional functions
other than membrane anchoring (27). NS5A also interacts
with a number of host cell factors, including the RNA-
activated protein kinase, PKR (29). Few and controversial
data about the eﬀect of NS5A on HCV IRES-mediated
translation have been reported (14,30); the central domain
of NS5A rather than its N-terminal region was suggested
to be responsible for all these eﬀects. Thus, our approach
led us to unveil an unsuspected function of the N-terminal
NS5A sequence in the regulation of HCV IRES-dependent
RNA translation. Whether this regulation functions
in the context of the intact protein still remains to be
investigated.
It was intriguing that the cell-free assay revealed an
eﬀect of GE4 peptide on cap-dependent translation,
whereas this was not apparent in growing cells.
Assuming that the GE4 peptide directly interacted with
some factors involved in the translation machinery, as
suggested by our results of cell-free assays, one hypothesis
is that it could be related to limited rate of active eIF2 or
eIF3, the only eukaryotic translation initiation factors
required by HCV IRES (4–6). Indeed, it was reported
that HCV IRES could be substantially inhibited by partial
depletion of eIF2g and eIF2Bg, the guanine nucleotide-
exchange factor responsible for recycling eIF2 to its active
GTP-bound state, whereas general protein translation and
cell growth remained unaﬀected, suggesting that HCV
IRES activity may depend on high levels of active eIF2,
in contrast to the cap (31). If GE4 peptide limited some-
how the rate of active eIF2 (or eIF3), this would impair
both HCV IRES-and cap-dependent translation in a cell-
free system, but become less sensitive for cap-dependent
translation in living cells, which may be able to regenerate
these translation factors at a threshold suﬃcient for the
cap, but not for the IRES.
In conclusion, this selection led to the discovery of func-
tional domains of the HCV genome. This strategy is par-
ticularly adapted to viruses, which fulﬁll a lot of functions
with a limited number of protein and genetic elements.
This method is of general interest and might prove
useful for the identiﬁcation of regulatory elements in
either viral or host cell genomes.
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